Safe anticoagulation for patients with CKD—are we there yet?

被引：0

作者：

Elsayed Z. Soliman

机构：

[1] Epidemiological Cardiology Research Center (EPICARE),

[2] Wake Forest School of Medicine,undefined

[3] Medical Center Boulevard,undefined

来源：

Nature Reviews Nephrology | 2012年 / 8卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Data from the ARISTOTLE trial showed that apixaban, compared with warfarin, reduced the rates of stroke, death and major bleeding in patients with atrial fibrillation, regardless of renal function. Is the problem of balancing the risks of thromboembolism and bleeding in patients with atrial fibrillation and chronic kidney disease finally solved?

引用

页码：689 / 690

页数：1

共 50 条

[1] Safe anticoagulation for patients with CKD-are we there yet?
Soliman, Elsayed Z.
NATURE REVIEWS NEPHROLOGY, 2012, 8 (12) : 689 - 690
[2] Are we safe yet?
Kumagai, J
Garwin, RL
IEEE SPECTRUM, 2003, 40 (01) : 63 - 64
[3] Are we safe yet?
Powell, B
FORTUNE, 2002, 146 (05) : 102 - +
[4] Are we safe yet?
Stewart, Jane
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[5] Safe Nanoparticles: Are We There Yet?
Najahi-Missaoui, Wided
Arnold, Robert D.
Cummings, Brian S.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 22
[6] Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
Pierangeli, S. S.
Erkan, D.
LUPUS, 2010, 19 (04) : 475 - 485
[7] Safe patient handling - Are we doing it yet?
Watters, Carol
ORTHOPAEDIC NURSING, 2008, 27 (01) : 38 - 41
[8] Safe and effective colon polypectomy in patients receiving uninterrupted anticoagulation: can we do it?
Kim, Hyun Gun
Friedland, Shai
GASTROINTESTINAL ENDOSCOPY, 2014, 79 (03) : 424 - 46
[9] Are We Safe Yet? How to Manage Financial Crises
Geithner, Timothy F.
FOREIGN AFFAIRS, 2017, 96 (01) : 54 - +
[10] Safety of Antidepressant Medications to Treat Comorbid Depression in CKD: Are We There Yet?
Hedayati, S. Susan
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (02): : 142 - 144

← 1 2 3 4 5 →